Aberration of lncRNA LINC00460 is a Promising Prognosis Factor and Associated with Progression of Clear Cell Renal Cell Carcinoma

References

• PadalaSA, KallamA. Clear cell renal carcinoma. In: StatPearls. StatPearls Publishing LLC; 2020.
   Google Scholar
• CapitanioU, MontorsiF. Renal cancer. Lancet. 2016;387(10021):894–906. doi:10.1016/S0140-6736(15)00046-X26318520
   PubMed Web of Science ®Google Scholar
• AroraRD, LimaiemF. Renal clear cell cancer. In: StatPearls. StatPearls Publishing LLC; 2020.
   Google Scholar
• MatsudaT, HoriM. Five-year relative survival rate of kidney and renal pelvis cancer in the USA, Europe and Japan. Jpn J Clin Oncol. 2015;45(1):136. doi:10.1093/jjco/hyu21625542962
   PubMed Web of Science ®Google Scholar
• IyerMK, NiknafsYS, MalikR, et al. The landscape of long noncoding RNAs in the human transcriptome. Nat Genet. 2015;47(3):199–208. doi:10.1038/ng.319225599403
   PubMed Web of Science ®Google Scholar
• CabiliMN, TrapnellC, GoffL, et al. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 2011;25(18):1915–1927. doi:10.1101/gad.1744661121890647
   PubMed Web of Science ®Google Scholar
• ShimaH, KidaK, AdachiS, et al. Lnc RNA H19 is associated with poor prognosis in breast cancer patients and promotes cancer stemness. Breast Cancer Res Treat. 2018;170(3):507–516. doi:10.1007/s10549-018-4793-z29693231
   PubMed Web of Science ®Google Scholar
• WangY, DingX, HuH, et al. Long non-coding RNA lnc-PCTST predicts prognosis through inhibiting progression of pancreatic cancer by downregulation of TACC-3. Int J Cancer. 2018;143(12):3143–3154. doi:10.1002/ijc.3165729978472
   PubMed Web of Science ®Google Scholar
• AngenardG, MerdrignacA, LouisC, EdelineJ, CoulouarnC. Expression of long non-coding RNA ANRIL predicts a poor prognosis in intrahepatic cholangiocarcinoma. Dig Liver Dis. 2019;51(9):1337–1343. doi:10.1016/j.dld.2019.03.01931040073
   PubMedGoogle Scholar
• QiL, ZhangT, YaoY, et al. Identification of lncRNAs associated with lung squamous cell carcinoma prognosis in the competitive endogenous RNA network. PeerJ. 2019;7:e7727. doi:10.7717/peerj.772731576252
   PubMed Web of Science ®Google Scholar
• ZhangY, LiuX, LiQ, ZhangY. lncRNA LINC00460 promoted colorectal cancer cells metastasis via miR-939-5p sponging. Cancer Manag Res. 2019;11:1779–1789. doi:10.2147/CMAR.S19245230863183
   PubMed Web of Science ®Google Scholar
• ZhuY, YangL, ChongQY, et al. Long noncoding RNA Linc00460 promotes breast cancer progression by regulating the miR-489-5p/FGF7/AKT axis. Cancer Manag Res. 2019;11:5983–6001. doi:10.2147/CMAR.S20708431308741
   PubMed Web of Science ®Google Scholar
• SongH, HeP, ShaoT, LiY, LiJ, ZhangY. Long non-coding RNA XIST functions as an oncogene in human colorectal cancer by targeting miR-132-3p. J buon. 2017;22(3):696–703.28730777
   PubMed Web of Science ®Google Scholar
• WeiH, HuJ, PuJ, et al. Long noncoding RNA HAGLROS promotes cell proliferation, inhibits apoptosis and enhances autophagy via regulating miR-5095/ATG12 axis in hepatocellular carcinoma cells. Int Immunopharmacol. 2019;73:72–80. doi:10.1016/j.intimp.2019.04.04931082725
   PubMed Web of Science ®Google Scholar
• DaM, MaJ, ZhangY, et al. High expression level of long non-coding RNA HOTAIR is associated with poor overall survival in gastric cancer patients: evidence from meta-analysis. J buon. 2017;22;4:911–918.29155520
   PubMed Web of Science ®Google Scholar
• JiangCY, GaoY, WangXJ, et al. Long non-coding RNA lnc-MX1-1 is associated with poor clinical features and promotes cellular proliferation and invasiveness in prostate cancer. Biochem Biophys Res Commun. 2016;470(3):721–727. doi:10.1016/j.bbrc.2016.01.05626797523
   PubMed Web of Science ®Google Scholar
• FanY, NanY, HuangJ, ZhongH, ZhouW. Up-regulation of inflammation-related LncRNA-IL7R predicts poor clinical outcome in patients with cervical cancer. Biosci Rep. 2018;38(3).
   Web of Science ®Google Scholar
• ZhengP, ZhangH, GaoH, et al. Plasma exosomal long noncoding RNA lnc-SLC2A12-10:1 as a novel diagnostic biomarker for gastric cancer. Onco Targets Ther. 2020;13:4009–4018. doi:10.2147/OTT.S25360032494155
   PubMed Web of Science ®Google Scholar
• El-KhazragyN, EsmaielMA, MohamedMM, HassanNS. Upregulation of long noncoding RNA Lnc-IRF2-3 and Lnc-ZNF667-AS1 is associated with poor survival in B-chronic lymphocytic leukemia. Int J Lab Hematol. 2020;42(3):284–291. doi:10.1111/ijlh.1316732083800
   PubMed Web of Science ®Google Scholar
• BlondeauJJ, DengM, SyringI, et al. Identification of novel long non-coding RNAs in clear cell renal cell carcinoma. Clin Epigenetics. 2015;7(1):10. doi:10.1186/s13148-015-0047-725685243
   PubMed Web of Science ®Google Scholar
• ZhangD, ZengS, HuX. Identification of a three-long noncoding RNA prognostic model involved competitive endogenous RNA in kidney renal clear cell carcinoma. Cancer Cell Int. 2020;20(1):319. doi:10.1186/s12935-020-01423-432694941
   PubMed Web of Science ®Google Scholar
• HuX, LiuW, JiangX, et al. Long noncoding RNA LINC00460 aggravates invasion and metastasis by targeting miR-30a-3p/Rap1A in nasopharyngeal carcinoma. Hum Cell. 2019;32(4):465–476. doi:10.1007/s13577-019-00262-431414345
   PubMed Web of Science ®Google Scholar
• WangHX, KangLJ, QinX, XuJ, FeiJW. LINC00460 promotes proliferation and inhibits apoptosis of non-small cell lung cancer cells through targeted regulation of miR-539. Eur Rev Med Pharmacol Sci. 2020;24(12):6752–6758.32633366
   PubMed Web of Science ®Google Scholar
• ZhangS, XuJ, WangH, GuoH. Downregulation of long noncoding RNA LINC00460 expression suppresses tumor growth in vitro and in vivo in gastric cancer. Cancer Biomark. 2019;24(4):429–437. doi:10.3233/CBM-18217730909185
   PubMed Web of Science ®Google Scholar
• YuanB, YangJ, GuH, MaC. Down-regulation of LINC00460 represses metastasis of colorectal cancer via WWC2. Dig Dis Sci. 2020;65(2):442–456. doi:10.1007/s10620-019-05801-531541369
   PubMed Web of Science ®Google Scholar
• XieM, LvY, LiuZ, et al. Identification and validation of a four-miRNA (miRNA-21-5p, miRNA-9-5p, miR-149-5p, and miRNA-30b-5p) prognosis signature in clear cell renal cell carcinoma. Cancer Manag Res. 2018;10:5759–5766. doi:10.2147/CMAR.S18710930532596
   PubMed Web of Science ®Google Scholar
• JinL, LiY, LiuJ, et al. Tumor suppressor miR-149-5p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma. Mol Med Rep. 2016;13(6):5386–5392. doi:10.3892/mmr.2016.520527121091
   PubMed Web of Science ®Google Scholar
• YeZM, YangS, XiaYP, et al. LncRNA MIAT sponges miR-149-5p to inhibit efferocytosis in advanced atherosclerosis through CD47 upregulation. Cell Death Dis. 2019;10(2):138. doi:10.1038/s41419-019-1409-430755588
   PubMed Web of Science ®Google Scholar
• LiF, ZhouX, ChenM, FanW. Regulatory effect of LncRNA DRAIC/miR-149-5p/NFIB molecular network on autophagy of esophageal cancer cells and its biological behavior. Exp Mol Pathol. 2020;116:104491. doi:10.1016/j.yexmp.2020.10449132659236
   PubMed Web of Science ®Google Scholar
• DongJ, TengF, GuoW, YangJ, DingG, FuZ. lncRNA SNHG8 promotes the tumorigenesis and metastasis by sponging miR-149-5p and predicts tumor recurrence in hepatocellular carcinoma. Cell Physiol Biochem. 2018;51(5):2262–2274. doi:10.1159/00049587130537734
   PubMedGoogle Scholar
• OkatoA, AraiT, YamadaY, et al. Dual strands of pre-miR-149 inhibit cancer cell migration and invasion through targeting FOXM1 in renal cell carcinoma. Int J Mol Sci. 2017;18(9):1969.
   PubMed Web of Science ®Google Scholar